{"id":"https://openalex.org/W1977572672","doi":"https://doi.org/10.4088/jcp.v67n0310","title":"The Effect of Dermatologic Precautions on the Incidence of Rash With Addition of Lamotrigine in the Treatment of Bipolar I Disorder","display_name":"The Effect of Dermatologic Precautions on the Incidence of Rash With Addition of Lamotrigine in the Treatment of Bipolar I Disorder","publication_year":2006,"publication_date":"2006-03-15","ids":{"openalex":"https://openalex.org/W1977572672","doi":"https://doi.org/10.4088/jcp.v67n0310","mag":"1977572672","pmid":"https://pubmed.ncbi.nlm.nih.gov/16649826"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v67n0310","doi":"https://doi.org/10.4088/jcp.v67n0310","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v67n0310","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046547929","display_name":"Terence A. Ketter","orcid":"https://orcid.org/0000-0001-5132-453X","observed_orcids":["https://orcid.org/0000-0001-5132-453X"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terence A. Ketter","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif, USA. tketter@stanford.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif, USA. tketter@stanford.edu","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064151665","display_name":"John H. Greist","orcid":"https://orcid.org/0000-0002-4712-6132","observed_orcids":["https://orcid.org/0000-0002-4712-6132"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John H. Greist","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"James A. Graham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James A. Graham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040619683","display_name":"JEREMY N. ROBERTS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeremy N. Roberts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035771255","display_name":"Thomas R. Thompson","orcid":"https://orcid.org/0000-0002-3951-5402","observed_orcids":["https://orcid.org/0000-0002-3951-5402"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas R. Thompson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072795896","display_name":"Kevin P. Nanry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin P. Nanry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3327,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.8639346,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"67","issue":"03","first_page":"400","last_page":"406"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bipolar-i-disorder","display_name":"bipolar I disorder","score":0.9800000190734863},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.5509999990463257},{"id":"https://openalex.org/keywords/dermatologic-adverse-events","display_name":"dermatologic adverse events","score":0.7200000286102295},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.5730000138282776},{"id":"https://openalex.org/keywords/prescribing-information","display_name":"prescribing information","score":0.5120000243186951},{"id":"https://openalex.org/keywords/mood-stabilizers","display_name":"mood stabilizers","score":0.35199999809265137},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.375},{"id":"https://openalex.org/keywords/adverse-drug-reaction-prevention","display_name":"adverse drug reaction prevention","score":0.4129999876022339},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.5080000162124634},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.3449999988079071},{"id":"https://openalex.org/keywords/adolescents-and-adults","display_name":"adolescents and adults","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.9780656099319458},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7642160654067993},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.6993989944458008},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6373088359832764},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6067205667495728},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.47083592414855957},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4683881103992462},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.17731019854545593},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.13936984539031982},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.05535036325454712},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010353","descriptor_name":"Patient Education as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011356","descriptor_name":"Product Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v67n0310","doi":"https://doi.org/10.4088/jcp.v67n0310","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v67n0310","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:16649826","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16649826","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2086074106","https://openalex.org/W2055121490","https://openalex.org/W1967735031","https://openalex.org/W2005114999","https://openalex.org/W2131305990","https://openalex.org/W2094313796","https://openalex.org/W2124410285","https://openalex.org/W2169199114","https://openalex.org/W7141760181","https://openalex.org/W4231819689"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Prescribing":[1],"recommendations":[2],"specify":[3],"that":[4,35,392,427,436],"lamotrigine":[5,36,64,93,120,196,359,397,457,477],"should":[6],"ordinarily":[7],"be":[8],"discontinued":[9,38],"at":[10,76,139,368],"the":[11,23,85,98,153,157,212,215,243,248,261,271,293,328,446],"first":[12],"sign":[13],"of":[14,17,41,51,63,67,80,87,100,107,115,137,163,183,193,214,245,289,298,308,316,335,379,395,403,468,488],"rash,":[15,112,475],"regardless":[16],"its":[18],"type":[19],"and":[20,116,204,226,263,270,345,348,352,365,371,382,388,407,465,471,476],"severity,":[21],"unless":[22],"rash":[24,43,69,89,164,246,337,413,421,464,470],"is":[25,37],"clearly":[26],"not":[27,208,429],"drug":[28],"related.":[29],"This":[30,95],"practice":[31],"helps":[32],"to":[33,49,60,91,104,145,180,197,222,230,257,283,306,319,362,474],"ensure":[34],"in":[39,47,53,121,156,211,330,341,401,423,437,450,484],"instances":[40],"serious":[42,323,463],"(an":[44],"event":[45,304],"occurring":[46],"up":[48],"0.13%":[50],"cases":[52,66],"bipolar":[54,124,131,491],"clinical":[55,255,425,482],"trials)":[56],"but":[57,432],"may":[58],"lead":[59],"unnecessary":[61],"discontinuation":[62,307,472],"for":[65,160],"nonserious":[68,88,111,166,188,336,420,469],"arising":[70],"from":[71,152,280],"nondrug":[72],"causes.":[73],"Measures":[74],"aimed":[75],"reducing":[77,161],"overall":[78],"occurrence":[79],"dermatologic":[81,108,185],"reactions":[82],"might":[83],"reduce":[84],"incidence":[86,334],"leading":[90,305],"premature":[92],"discontinuation.":[94],"study":[96,309,329,453],"assessed":[97,259],"impact":[99],"specific":[101],"instructions":[102,155],"designed":[103],"decrease":[105,181],"risk":[106,162,182],"reactions,":[109],"including":[110,165,187,313],"during":[113,190,247,327],"initiation":[114],"early":[117],"treatment":[118,249],"with":[119,123,129,201,260,343,461,481,490],"patients":[122,227,234,291,300,342,489],"I":[125,132,492],"disorder.":[126,493],"METHOD:":[127],"Outpatients":[128],"DSM-IV-diagnosed":[130],"disorder":[133],">/=":[134],"13":[135],"years":[136],"age":[138],"188":[140],"sites":[141],"were":[142,207,219,228,235,278,325,416],"randomly":[143,236],"assigned":[144],"receive":[146],"Usual":[147],"Care":[148],"Precautions":[149,170],"(UCP;":[150],"precautions":[151,172,178],"patient":[154],"prescribing":[158],"information":[159],"rash)":[167,189],"or":[168,311],"Dermatologic":[169],"(DP;":[171],"as":[173],"above":[174],"[UCP]":[175],"plus":[176],"additional":[177,396],"intended":[179],"any":[184],"reaction":[186],"12":[191,372],"weeks":[192,369,386],"adding":[194],"open-label":[195],"concomitant":[198],"medications.":[199],"Patients":[200],"comorbid":[202],"medical":[203],"psychiatric":[205],"problems":[206,218],"excluded":[209],"unless,":[210],"opinion":[213],"investigators,":[216],"these":[217],"sufficiently":[220],"severe":[221],"preclude":[223],"participation.":[224],"Investigators":[225],"blinded":[229],"which":[231,415],"precaution":[232],"group":[233],"assigned.":[237],"The":[238,333],"primary":[239],"outcome":[240,252],"measure":[241],"was":[242,338,360,458,479],"rate":[244],"period.":[250],"Secondary":[251],"measures":[253],"included":[254],"response":[256],"lamotrigine,":[258],"investigator-":[262],"self-rated":[264],"Clinical":[265,272],"Global":[266,273],"Impressions-Bipolar":[267],"version":[268],"(CGI-BP)":[269],"Impressions-Efficacy":[274],"Index":[275],"(CGI-EI).":[276],"Data":[277],"collected":[279],"August":[281,284],"2003":[282],"2004.":[285],"RESULTS:":[286],"867":[287],"(74%)":[288],"1175":[290,299,317],"completed":[292],"study.":[294],"Only":[295],"182":[296],"(15%)":[297],"had":[301],"an":[302],"adverse":[303],"medication":[310],"withdrawal,":[312],"62":[314],"(5.3%)":[315],"due":[318,473],"non-serious":[320,412],"rash.":[321],"No":[322],"rashes":[324],"reported":[326,391],"either":[331],"group.":[332],"similarly":[339],"low":[340,466],"UCP":[344,406],"DP":[346,408,431],"(8.8%":[347],"8.6%,":[349],"respectively).":[350],"CGI-BP-Severity":[351],"-Improvement":[353],"scores":[354,367],"indicated":[355],"mood":[356,380],"improvement":[357,483],"when":[358],"added":[361],"existing":[363],"therapy,":[364],"CGI-EI":[366],"5":[370,387],"reflected":[373],"a":[374,438,485],"favorable":[375],"balance":[376],"between":[377],"control":[378],"symptoms":[381],"tolerability.":[383],"At":[384],"both":[385],"12,":[389],"investigators":[390],"therapeutic":[393],"effects":[394,400],"outweighed":[398],"side":[399],"74%":[402],"subjects.":[404],"CONCLUSION:":[405],"yielded":[409],"low,":[410],"similar":[411],"rates,":[414],"marginally":[417,433],"lower":[418],"than":[419,435],"rates":[422],"prior":[424,439],"trials":[426],"did":[428],"utilize":[430],"higher":[434],"open":[440],"case":[441],"series":[442],"using":[443],"DP.":[444],"Nevertheless,":[445],"results":[447],"are":[448],"encouraging:":[449],"this":[451],"large":[452],"reflecting":[454],"real-world":[455],"use,":[456],"well":[459],"tolerated":[460],"no":[462],"incidences":[467],"therapy":[478],"associated":[480],"heterogeneous":[486],"cohort":[487]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}